AMNIOmics: A Prenatal Rapid Genome Validation Study
NCT05834621 is an observational study sponsored by Mayo Clinic. As of 21 Nov 2026, it was withdrawn. It studies Amniocentesis Affecting Fetus or Newborn, Family Members and 2 more conditions. The registry lists an enrollment of 0 participants. The registry lists a start date of 7 Jan 2025 and a primary completion date of 7 Jan 2025.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT05834621 |
| Status | Withdrawn |
| Study type | Observational study |
| Lead sponsor | Mayo Clinic |
| Enrollment | 0 |
| Conditions | Amniocentesis Affecting Fetus or Newborn, Family Members, Genetic Predisposition Suspected and Multiple Anomalies of Fetus |
| Start | 7 Jan 2025 |
| Primary completion | 7 Jan 2025 |
| Study completion | 7 Jan 2025 |
| Last update posted | 5 Sept 2025 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Myra Wick, MD, PhD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT05834621
Each answer restates registry values shown on this page.
What is NCT05834621?
NCT05834621 is an observational study sponsored by Mayo Clinic. It studies Amniocentesis Affecting Fetus or Newborn, Family Members and 2 more conditions.
Who leads NCT05834621?
The registry names Myra Wick, MD, PhD (principal investigator, Mayo Clinic) as the overall official.
When did NCT05834621 end?
The registry lists a primary completion date of 7 Jan 2025 and a study completion date of 7 Jan 2025. The sponsor last updated the record on 5 Sept 2025.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.